RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 131 filers reported holding RELAY THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 13.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,173,732 | -33.5% | 258,470 | -0.6% | 0.00% | 0.0% |
| Q2 2023 | $3,266,630 | +78937.7% | 260,082 | +3.6% | 0.00% | -50.0% |
| Q1 2023 | $4,133 | +17.6% | 250,937 | +6.7% | 0.00% | +100.0% |
| Q4 2022 | $3,514 | -99.9% | 235,203 | -14.2% | 0.00% | -50.0% |
| Q3 2022 | $6,133,000 | +35.7% | 274,178 | +1.6% | 0.00% | 0.0% |
| Q2 2022 | $4,520,000 | -19.7% | 269,846 | +24.2% | 0.00% | 0.0% |
| Q1 2022 | $5,631,000 | -5.1% | 217,323 | +2.5% | 0.00% | 0.0% |
| Q4 2021 | $5,933,000 | -25.3% | 212,051 | -1.0% | 0.00% | 0.0% |
| Q3 2021 | $7,945,000 | +4.6% | 214,218 | +3.2% | 0.00% | 0.0% |
| Q2 2021 | $7,593,000 | +40.3% | 207,511 | +32.6% | 0.00% | 0.0% |
| Q1 2021 | $5,411,000 | +1.2% | 156,534 | +21.6% | 0.00% | 0.0% |
| Q4 2020 | $5,349,000 | -0.4% | 128,691 | +2.1% | 0.00% | 0.0% |
| Q3 2020 | $5,368,000 | – | 126,039 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 4,068,574 | $68,149,000 | 5.76% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $467,408,000 | 3.71% |
| BVF INC/IL | 4,384,805 | $73,445,000 | 3.55% |
| Boxer Capital, LLC | 2,669,132 | $44,708,000 | 2.83% |
| Nextech Invest Ltd. | 475,485 | $7,964,000 | 2.69% |
| EcoR1 Capital, LLC | 3,723,541 | $62,369,000 | 2.15% |
| HARBOURVEST PARTNERS LLC | 296,402 | $4,965,000 | 1.63% |
| Integral Health Asset Management, LLC | 436,262 | $7,307,000 | 1.50% |
| Alphabet Inc. | 1,568,753 | $26,277,000 | 1.43% |
| Fernwood Investment Management, LLC | 185,063 | $3,100,000 | 1.34% |